+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Aesthetics Market, 2023-2035 - Distribution by Type of Product and/or Device Offered, Type of Procedure, End User, Gender, Distribution Channel, and Key Geographical Regions: Industry Trends and Forecasts

  • PDF Icon

    Report

  • 294 Pages
  • January 2024
  • Region: Global
  • Roots Analysis
  • ID: 5925449

Surge in Demand for Medical Aesthetics Propelled by Social Media, Celebrity Endorsements, and COVID-19's Impact

The global medical aesthetics market size is estimated to be $35 billion in 2023 and is anticipated to grow at a compounded annual growth rate (CAGR) of around 9.3% over the forecast period 2023-2035. In the recent years, the increased desire to achieve prolong youthfulness, influence of social media, technological advancements, celebrity endorsements and the hype bolstered by certain beauticians and medical professionals have led to a surge in the demand for medical aesthetic solutions. It is worth highlighting that COVID has also contributed significantly towards the increased number of annual aesthetic treatments. In fact, according to the American Academy of Facial Plastic and Reconstructive Surgery, the pandemic has led to a 10% increase in the number of cosmetic surgeries. Medical aesthetics is a well-established branch of modern medicine, which primarily focuses on enhancing the cosmetic appearance of an individual without clinical surgery. These treatments are mainly used for anti aging purposes by reducing fine lines and wrinkles, lifting flabby skin and skin rejuvenation. Additionally, medical aesthetic procedures can also help in reducing excess fat and cellulite, unwanted hair, and spider veins. Further, according to a study conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), over 15 million invasive aesthetic procedures and 19 million non-invasive aesthetic procedures have been performed in 2022, globally. It is worth mentioning that nearly 90% of the industry clientele are women, however, these aesthetic procedures are also gaining popularity among men.

Owing to the widespread adoption of these procedures, medical aesthetics companies are actively pursuing the development of medical aesthetic products and devices, primarily focusing on the development of non-invasive or minimally invasive solutions. These treatments usually do not involve full-fledged surgical procedure, thereby causing lesser pain, minimal discomfort, fewer risks and short hospital stays, while offering long-lasting results. Popular minimally invasive medical aesthetic procedures include Botulinum toxin and aesthetic fillers that are mainly utilized for improving glabellar lines and skin tightening. It is worth highlighting that benefits of aesthetic procedures aren’t just limited to cosmetic appearance but also aid in addressing other commonly experienced healthcare concerns. For instance Botulinum toxin helps in limiting sweating and migraines. Further, some of the commonly performed non invasive procedures include body contouring, laser hair removal, tattoo removal and nail treatments. Body contouring devices are commonly employed for skin tightening, fat reduction and cellulite reduction purposes.

Medical aesthetic procedures can be performed at a medical aesthetic clinic and also at medical spas by various professionals, including dermatologists, plastic surgeons, physicians, nurse practitioners, registered nurses and even aestheticians. It is interesting to note that more than 70% of the today’s medical aesthetics market is dominated by hospitals, clinics and medical spas. In addition, South Korea, the plastic surgery capital, boasts the highest rate of cosmetic surgery per capita globally. This can be attributed to the well-established cosmetic surgery infrastructure and experienced medical professionals promoting aesthetics medical tourism within the country. However, the concern associated with medical aesthetic treatments is the violation of regulatory guidelines by certain medical professionals and medical aesthetic companies that can lead to side-effects. Therefore, it is crucial for the patient to undergo treatment by a licensed medical professional using certified aesthetic devices to avoid potential risks and complications. By overcoming these challenges and fulfilling the rising demand for medical aesthetic procedures, the medical aesthetics companies are likely to experience significant market growth over the forecast period.

Key Market Insights

The Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered (Botox, Dermal Fillers, Chemical Peels, Body Contouring, Gluteal Implants, Hair Removal, Breast Implants and Other Products and / or Devices), Type of Procedure (Non-invasive, Minimally Invasive and Invasive), End User (Hospitals, Clinics / Med Spas and Dermatology / Cosmetology Centers, and Other end users), Gender (Male and Female), Distribution Channel (Direct Distribution and Indirect Distribution), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunities associated with the medical aesthetics market, during the given forecast period. The market report highlights the efforts of medical aesthetics companies engaged in this growing segment of the cosmetic industry. Key takeaways of the medical aesthetics market report are briefly discussed below.

Current Market Landscape of the Medical Aesthetics Companies

Presently, more than 200 medical aesthetics companies are engaged in offering various products and devices to fulfil aesthetic requirements of clients. The landscape of medical aesthetics features a mix of large, mid-sized, small and very small firms. These players offer numerous products and / or devices, including Botulinum toxin, aesthetic fillers, chemical peels, microdermabrasion devices, microneedling devices, nose lifting products, thread lift products, aesthetic implants, facial aesthetics devices, gluteal implants, body contouring devices, laser hair removal devices, intense pulsed light (IPL) hair removal devices, breast implants, breast lifting / reconstruction devices, nail treatment devices and tattoo removal devices. These products and / or devices can be used for several aesthetic purposes, such as skin resurfacing, skin lightening, skin tightening, fat reduction, cellulite reduction and breast augmentation. Additionally, medical aesthetic companies offer all types of invasive, non invasive and minimally invasive solutions to address the requirements of all end users, such as hospitals, medical aesthetic clinic and individuals in home care settings.

Popular Medical Aesthetic Procedures

According to a study conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), in 2022, Botulinum toxin was the most popular minimally invasive medical aesthetic procedure with over nine million procedures performed worldwide. The cost of the treatment usually ranges from USD 400-500, making it a cost-efficient alternative as compared to surgical approaches while providing immediate results. This is followed by dermal filler procedures, which constitute 25% of the total number of non-surgical procedures. Further, breast implants are the most commonly performed surgical procedures, globally. This can be attributed to increased incidences of breast cancer and constant innovations occurring in the field of breast implants. It is interesting to note that several innovations are going on to provide natural looking results to people seeking breast augmentation procedures. In fact, researchers in this field are working in developing micro-implants. These breast implants are designed in such a way that they can be inserted into the breast tissue by making small incisions and thus providing more natural looking results and ensuring maximal comfort. Additionally, some studies are also investigating the potential of stem cell breast implants, which involve removal of stem cells from the stomach and injecting them into the breasts that may result in one cup increase in size. Further, some plastic surgeons are also working on developing lightweight silicone aesthetic implants, wherein they are trying to reduce the weight of weight by 30%. The increasing efforts of researchers will significantly accelerate the growth of breast implants market.

Market Trends: Medical Aesthetics Companies Partnering to Expand their Product Portfolios

In recent years, several partnerships have been inked by various stakeholders in order to consolidate their presence and enhance their capabilities / product portfolio to meet the growing demand for medical aesthetic procedures. In fact, the partnership activity has witnessed a CAGR of ~15% in the past few years. It is worth mentioning that acquisitions and mergers emerged as the most common type of partnership model adopted by stakeholders in this domain. For instance, Reveal Lasers acquired NEOconcepts (July 2023) to gain their extensive medical aesthetic devices portfolio, particularly intended for facial aesthetic purposes. Further, the partnerships signed in the medical aesthetics market have been primarily focused on distribution of different products and devices across multiple geographies. In addition, some medical aesthetic companies have also collaborated for product / technology integration purposes to advance the development of innovative aesthetic devices. The analyst expects the medical aesthetic companies to continue to partner with other firms, hospitals and medical aesthetic clinic to expand their product portfolio in order to meet the rising demand of global clientele and drive the medical aesthetics market growth during the forecast period.

Market Trends: Medical Aesthetics Companies Have Raised Significant Capital in the Past Few Years

Over the years, monetary assistance from angel investors, venture capitalists, and funding schemes of various public and private organizations / funds, along with assistance from regulatory authorities, have allowed medical aesthetic companies to progress their R&D efforts related to the development of medical aesthetic products / devices. It is important to highlight that over USD 3.6 billion has been invested in this domain, since 2018. Examples of the players that have raised more than USD 30 million capital in 2023 include (in decreasing order of capital raised) Galderma (USD 1,000 million), Aeon Biopharma (USD 125 million) and Establishment Labs (USD 90 million). It is worth noting that most of the funding instances reported within this industry were venture capital rounds indicative of the emergence of the new players in this domain.

Medical Aesthetics Market Size: North America to Hold the Largest Market Share, While Asia-Pacific to Witness Highest Market Growth

Presently, close to 40% of the medical aesthetics market is captured by companies based in North America. Driven by the rising interest in advanced medical aesthetic solutions and increasing demand of medical aesthetic treatments in the cosmetic industry, the market size for medical aesthetic solutions in North America is anticipated to grow at a CAGR of 12%, during the forecast period, 2023-2035. A number of factors contribute to the region’s dominance in this industry which include the presence of several well-established companies with extensive manufacturing capabilities that foster innovation and drive the demand for medical aesthetic products and devices. It is worth highlighting that maximum number of medical aesthetic procedures were performed in the US, in 2022. This can be attributed to the increase in disposable income due to money saved on other things, such as travel and dining out during the pandemic. Additionally, in terms of market growth, the medical aesthetics market in Asia-Pacific is likely to grow at a relatively faster pace in the long term. It is worth highlighting that nearly 40% of the Asian medical aesthetics market is dominated by China and South Korea. This can be attributed to growing aesthetic awareness amongst the population and increasing aesthetics medical tourism in the region. Moreover, developing healthcare infrastructure and affordable price of treatments in this region is likely to propel the market.

Market Analysis: Minimally Invasive Procedures to Continue to Dominate the Medical Aesthetics Market

Non-surgical procedures capture the largest current market share and are likely to dominate the future market as well. This can be attributed to the immediate results that can be provided with these procedures while ensuring patient safety. Moreover, these procedures are cost effective when compared with surgical aesthetic procedures. The most commonly performed minimally aesthetic procedures include botulinum toxin and aesthetic fillers employed for skin rejuvenation and skin tightening. It is worth noting that botulinum toxin constitutes nearly 49% of the total non-surgical procedures performed in the year 2022, contributing significantly towards medical aesthetics industry growth. Companies, such as Merz Pharma offers uniquely purified botulinum toxin that can improve the facial appearance by reducing moderate to severe lines in an effective manner.

Medical Aesthetics Market: Key Growth Drivers

In the last few years, several factors have contributed towards the transformation of the medical aesthetics market. The increasing geriatric and obese population, lower treatment costs and fewer risks have contributed to the popularity of these procedures. Moreover, employment of effective marketing strategies in future is likely to drive the market growth in the coming years. It is interesting to note that COVID-19 pandemic has also contributed to the rising demand for these procedures. This is due to the shift in the global work culture, with more people frequently working from their homes and attending online meetings. While most of the online applications provide options to apply various filters and effects, platforms, such as Zoom does not offer any such functionalities making people feel insecure about their appearance. This self-consciousness among people, popularly termed as “Zoom Effect” has led to an increased interest in medical aesthetic procedures, contributing to overall medical aesthetics industry growth.

Key Players Offering Medical Aesthetic Solutions

Examples of the key companies engaged in the medical aesthetics market (the complete list of players is available in the full report) include (in alphabetic order) ADSS, Allergan Aesthetics, Astiland, Beijing Kes Biological Technology, BTL Aesthetics, Candela Medical, Classys, Croma Pharma, Cynosure, Daeyang Medical, Establishment Labs, Galderma, Guangzhou Itech Aesthetics, IBSA, Lumenis, Lutronic, MedicalZone, Mentor, Sanhe Medical, Shanghai Haohai Biological Technology, Sinclair Pharma, Sincoheren, Skin Tech Pharma, Wontech and Zesay Beauty. This market report also includes an easily searchable excel database of all the medical aesthetic companies worldwide.

Recent Developments in the Medical Aesthetics Market

Several recent developments have taken place in the field of medical aesthetics over the past few years. Some of these recent initiatives have been mentioned below. These developments, even though took place post the release of the market report, substantiate the overall market trends that have been outlined in the analyses.

In July 2023, a plant derived extracellular nanoparticle (PDEN) technology was supplied to S-Thetics, medical aesthetic clinic in UK. The technology is designed to help the skin’s signaling pathways to rebalance with the plant version of human exosomes to target inflammation. The platform rejuvenates and revitalizes the skin through peptides, growth factors, liposomes and amino acids.

Technological advancements have also contributed to the popularity of medical aesthetic procedures. Therefore, to provide less invasive, more precise and interactive sessions to the customers, stakeholders engaged in this domain are integrating advanced technologies in their practice. For instance, in January 2023, Galderma launched FACE, an aesthetic visualization solution that can simulate the results of injectable procedures using digital face assessment. The application permits advanced wrinkle detection for close to 20 injectable treatments by comparing patient’s images before and after the treatment procedure.

Scope of the Report

The market report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in providing medical aesthetic solutions. The different industry segments are highlighted below:

Medical Aesthetics Market: Report Attribute / Market Segmentation

  • Base Year: 2022
  • Forecast Period: 2023-2035
  • Historical Trends: 2018-2022
  • Market Size 2023: $35 Billion
  • CAGR: 9.3%
  • Type of Product and / or Device Offered
    • Botulinum toxin
    • Dermal Fillers
    • Chemical Peels
    • Body Contouring
    • Gluteal Implants
    • Hair Removal
    • Breast Implants
    • Other Products / Devices
  • Type of Procedure
    • Non Invasive
    • Minimally Invasive
    • Invasive
  • End User
    • Hospitals
    • Clincs / Med Spas and Dermatology / Cosmetology Centers
    • Other end users
    • Gender
    • Male
    • Female
  • Distribution Channel
    • Direct Distribution
    • Indirect Distribution
  • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and North Africa
    • Latin America
  • Key Companies Profiled
    • ADSS
    • Allergan Aesthetics
    • Astiland, Beijing Kes Biological Technology
    • BTL Aesthetics
    • Candela Medical
    • Classys
    • Croma Pharma
    • Cynosure
    • Daeyang Medical
    • Establishment Labs
    • Galderma
    • Guangzhou Itech Aesthetics
    • IBSA
    • Lumenis
    • Lutronic
    • MedicalZone
    • Mentor
    • Sanhe Medical
    • Shanghai Haohai Biological Technology
    • Sinclair Pharma
    • Sincoheren
    • Skin Tech Pharma
    • Wontech
    • Zesay Beauty

(Full list of ~200 companies captured in the market landscape analysis of the report)

  • Excel Data Packs (Complimentary)
    • Market Landscape Analysis
    • Company Competitiveness Analysis
    • Partnerships and Collaborations
    • Funding and Investments Analysis
    • Market Forecast and Opportunity Analysis
  • Customization Scope: 15% Free Customization Option (equivalent to 5 analysts working days)

Amongst other elements, the market report includes:

  • A preface providing an introduction to the full report, Medical Aesthetics Market, 2018-2035.
  • An outline of the systematic research methodology adopted to conduct the study on medical aesthetics market, providing insights on the various assumptions, methodologies and quality control measures employed to ensure accuracy and reliability of the findings.
  • An overview of economic factors that impact the overall medical aesthetics market, including historical trends, currency fluctuation, foreign exchange impact, recession and inflation measurement.
  • An executive summary of the insights captured during the research. It offers a high-level view of the current state of the medical aesthetics market and its likely evolution, in the mid to long term.
  • A general overview on medical aesthetics, their evolution, types of medical aesthetic procedures and application areas of medical aesthetic solutions. Additionally, the chapter provides information on the advantages of these procedures over conventional beauty treatments and associated side effects. It also discusses the key growth drivers, emerging technologies, key challenges and future perspectives in this domain.
  • An overview of the current market landscape of medical aesthetic companies, featuring information on year of establishment, company size (in terms of number of employees) and location of headquarters, type of offering (product and / or device), type of products and / or devices offered (Botox, dermal fillers, chemical peels, microdermabrasion devices, microneedling devices, nose reshaping implants / lifting products, thread lift products, facial implants, facial aesthetic devices, gluteal implants, body contouring devices, laser hair removal devices, IPL devices, breast implants, breast lifting / reconstruction devices, nail treatment devices and tattoo removal devices), application area (skin resurfacing, skin lightening, skin tightening, fat reduction, cellulite reduction and breast enhancement), type of procedure (invasive, non-invasive and minimally invasive) and end user (hospitals / clinics / medical spas, dermatology centers / cosmetic centers and others).
  • Elaborate profiles of companies offering products and / or devices for medical aesthetic procedures, featuring information on their year of establishment, location of headquarters, company size (in terms of number of employees), leadership team, financial information (if available), medical aesthetics portfolio, recent developments and an informed future outlook.
  • A detailed competitiveness analysis of medical aesthetic companies based on several relevant parameters, such as company strength (in terms of number of years since it was established), portfolio strength (in terms of type of offering, type of product and / or device offered and type of procedure) and number of end users served.
  • An analysis of the partnerships and collaborations inked in the medical aesthetics market, during the period 2018-2023, based on several parameters, such as year of partnership, type of partnership, focus area, most active players (in terms of number of partnerships) and geographical analysis.
  • An analysis of the funding and investments made in the medical aesthetics market, during the period 2018-2023, including seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings, at various stages of development in companies that are engaged in this field, based on several parameters, such as year-wise trend of funding instances, amount invested, type of funding, company size, geographical analysis, leading players (in terms of number of funding instances and amount raised) and investors (in terms of number of funding instances).
  • An in-depth analysis of the factors that can impact the growth of the medical aesthetics market. It also features identification and analysis of key drivers, potential restraints, emerging opportunities and existing challenges.
  • A detailed market forecast analysis in order to estimate the existing market size and future opportunity for medical aesthetics products over the next twelve years. Based on multiple parameters, likely adoption trends and number of medical aesthetic procedures performed, the analyst has provided an informed estimate on the market evolution during the forecast period 2023-2035. The report also features the likely distribution of the historical, current and forecasted opportunity within the medical aesthetics products market.

One of the key objectives of the market report was to evaluate the primary growth drivers and estimate the future market growth potential associated with the medical aesthetics market, over the forecast period. The analyst has provided informed estimates on the likely evolution of the market size for the forecast period, 2023-2035. The year-wise projections of the current and future opportunity for medical aesthetics market have been segmented based on relevant parameters, such as number of surgical and non-surgical medical aesthetic procedures performed annually and cost of each procedure. The market report also features the likely distribution of the current and forecasted opportunity across type of product and / or device offered (botox, dermal fillers, chemical peels, body contouring, hair removal, breast implants, gluteal implants and other products and / or devices), type of procedure (non-invasive, minimally invasive and invasive), end user (hospitals, clinics / med spas and dermatology / cosmetology centers, and other end users), gender (male and female), distribution channel (direct distribution and indirect distribution) and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America). In order to account for future uncertainties and to add robustness to the model, the analyst has provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in the market report were influenced by discussions held with stakeholders in the industry. The report features detailed transcripts of interviews held with the following stakeholders:

  • Aesthetic Physician, Director and Chief Medical Advisor of an Indian Company
  • Senior Resident, Dermatology of an Indian based large Hospital
  • Clinical and Aesthetic Dermatologist of an Indian based large Medical Research Institute

Further, all actual figures have been sourced and analyzed from publicly available information forums and secondary research inputs. Financial figures mentioned in this report are in USD, unless otherwise specified.

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Concept of Medical Aesthetics
5.3. Evolution of Medical Aesthetics
5.4. Types of Medical Aesthetic Procedures
5.4.1. Non-invasive Procedures
5.4.1.1. Facial Aesthetics
5.4.1.1.1. Botulinum Toxin
5.4.1.1.2. Dermal Fillers
5.4.1.1.3. Chemical Peels
5.4.1.1.4. Microdermabrasion
5.4.1.1.5. Microneedling
5.4.1.1.6. Thread Lift
5.4.1.2. Body Contouring
5.4.1.3. Hair Removal
5.4.1.3.1. Intense Pulse Light Hair Removal
5.4.1.3.2. Laser Hair Removal
5.4.1.4. Tattoo Removal
5.4.1.5. Nail Treatment
5.4.1.6. Eyelash Treatment
5.4.1.7. Permanent Make-up
5.4.2. Invasive Procedures
5.4.2.1. Breast Surgery
5.4.2.2. Gluteal Implants
5.4.2.3. Facial Surgery
5.4.2.4. Liposuction
5.4.2.5. Cosmetic Gynecology
5.5. Advantages of Medical Aesthetics
5.6. Side Effects of Medical Aesthetics
5.7. Key Growth Drivers
5.8. Emerging Technologies in Medical Aesthetics
5.8.1. Virtual Reality in Medical Aesthetics
5.8.2. Augmented Reality in Medical Aesthetics
5.8.3. Artificial Intelligence in Medical Aesthetics
5.8.4. Telemedicine in Medical Aesthetics
5.9. Key Challenges of Medical Aesthetics
5.10. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Aesthetic Companies: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
6.2.6. Analysis by Company Size and Location of Headquarters (Region)
6.2.7. Analysis by Type of Offering
6.2.8. Analysis by Type of Products and / or Devices Offered
6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
6.2.11. Analysis by Type of Hair Removal Devices Offered
6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
6.2.13. Analysis by Application Area
6.2.14. Analysis by Type of Procedure
6.2.15. Analysis by End-user
6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Detailed Company Profiles of Key Players
7.2.1. Companies Headquartered in North America
7.2.1.1. Allergan Aesthetics
7.2.1.1.1. Company Overview
7.2.1.1.2. Financial Information
7.2.1.1.3. Medical Aesthetics Portfolio
7.2.1.1.4. Recent Developments and Future Outlook
7.2.1.2. Candela Medical
7.2.1.2.1. Company Overview
7.2.1.2.2. Medical Aesthetics Portfolio
7.2.1.2.3. Recent Developments and Future Outlook
7.2.1.3. Cynosure
7.2.1.3.1. Company Overview
7.2.1.3.2. Medical Aesthetics Portfolio
7.2.1.3.3. Recent Developments and Future Outlook
7.2.1.4. Lutronic
7.2.1.4.1. Company Overview
7.2.1.4.2. Medical Aesthetics Portfolio
7.2.1.4.3. Recent Developments and Future Outlook
7.2.1.5. Mentor
7.2.1.5.1. Company Overview
7.2.1.5.2. Medical Aesthetics Portfolio
7.2.1.5.3. Recent Developments and Future Outlook
7.2.2. Companies Headquartered in Europe
7.2.2.1. BTL Aesthetics
7.2.2.1.1. Company Overview
7.2.2.1.2. Medical Aesthetics Portfolio
7.2.2.1.3. Recent Developments and Future Outlook
7.2.2.2. Croma Pharma
7.2.2.2.1. Company Overview
7.2.2.2.2. Financial Information
7.2.2.2.3. Medical Aesthetics Portfolio
7.2.2.2.4. Recent Developments and Future Outlook
7.2.2.3. Galderma
7.2.2.3.1. Company Overview
7.2.2.3.2. Financial Information
7.2.2.3.3. Medical Aesthetics Portfolio
7.2.2.3.4. Recent Developments and Future Outlook
7.2.2.4. IBSA
7.2.2.4.1. Company Overview
7.2.2.4.2. Medical Aesthetics Portfolio
7.2.2.4.3. Recent Developments and Future Outlook
7.2.2.5. Sinclair Pharma
7.2.2.5.1. Company Overview
7.2.2.5.2. Medical Aesthetics Portfolio
7.2.2.5.3. Recent Developments and Future Outlook
7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
7.2.3.1. Classys
7.2.3.1.1. Company Overview
7.2.3.1.2. Financial Information
7.2.3.1.3. Medical Aesthetics Portfolio
7.2.3.1.4. Recent Developments and Future Outlook
7.2.3.2. Daeyang Medical
7.2.3.2.1. Company Overview
7.2.3.2.2. Medical Aesthetics Portfolio
7.2.3.2.3. Recent Developments and Future Outlook
7.2.3.3. Establishment Labs
7.2.3.3.1. Company Overview
7.2.3.3.2. Financial Information
7.2.3.3.3. Medical Aesthetics Portfolio
7.2.3.3.4. Recent Developments and Future Outlook
7.2.3.4. Lumenis
7.2.3.4.1. Company Overview
7.2.3.4.2. Medical Aesthetics Portfolio
7.2.3.4.3. Recent Developments and Future Outlook
7.2.3.5. Shanghai Haohai Biological Technology
7.2.3.5.1. Company Overview
7.2.3.5.2. Financial Information
7.2.3.5.3. Medical Aesthetics Portfolio
7.2.3.5.4. Recent Developments and Future Outlook
7.3. Short Profiles of Other Prominent Players
7.3.1. ADSS
7.3.1.1. Company Overview
7.3.1.2. Medical Aesthetics Portfolio
7.3.2. Astiland
7.3.2.1. Company Overview
7.3.2.2. Medical Aesthetics Portfolio
7.3.3. Beijing Kes Biological Technology
7.3.3.1. Company Overview
7.3.3.2. Medical Aesthetics Portfolio
7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
7.3.4.2. Medical Aesthetics Portfolio
7.3.5. MedicalZone
7.3.5.1. Company Overview
7.3.5.2. Medical Aesthetics Portfolio
7.3.6. Sanhe Medical
7.3.6.1. Company Overview
7.3.6.2. Medical Aesthetics Portfolio
7.3.7. Sincoheren
7.3.7.1. Company Overview
7.3.7.2. Medical Aesthetics Portfolio
7.3.8. Skin Tech Pharma
7.3.8.1. Company Overview
7.3.8.2. Medical Aesthetics Portfolio
7.3.9. Wontech
7.3.9.1. Company Overview
7.3.9.2. Medical Aesthetics Portfolio
7.3.10. Zesay Beauty
7.3.10.1. Company Overview
7.3.10.2. Medical Aesthetics Portfolio
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Key Assumptions and Parameters
8.3. Methodology
8.4. Medical Aesthetics: Company Competitiveness Analysis
8.4.1. Companies based in North America
8.4.2. Companies based in Europe
8.4.3 Companies based in Asia-Pacific and Rest of the World
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Medical Aesthetics: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.4. Analysis by Geography
9.4.1. Local and International Agreements
9.4.2. Intracontinental and Intercontinental Agreements
10. FUNDING AND INVESTMENTS
10.1. Chapter Overview
10.2. Funding Models
10.3. Medical Aesthetics: Funding and Investments
10.3.1. Analysis by Year of Funding
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Analysis by Year and Type of Funding
10.3.5. Analysis by Type of Funding and Amount Invested
10.3.6. Analysis by Geography
10.3.7. Most Active Players
10.3.7.1. Analysis by Number of Funding Instances
10.3.7.2. Analysis by Amount Raised
10.3.8. Leading Investors: Analysis by Number of Funding Instances
10.3.9. Analysis by Company Size and Amount Invested
10.4. Concluding Remarks
11. DELT ANALYSIS
11.1. Chapter Overview
11.2. Methodology
11.3. Key Parameters
11.3.1. Demographical Factors
11.3.2. Environmental Factors
11.3.3. Legal Factors
11.3.4. Technological Factors
11.4. Medical Aesthetics: DELT Analysis
11.4.1. Allergan Aesthetics
11.4.2. Candela
11.4.3. Cutera
11.4.4. Biotechitalia
11.4.5. Sinclair Pharma
11.4.6. Merz Pharma
11.4.7. Dermosistemi
11.4.8. Alma Lasers
11.4.9. Bison Medical
11.5. Conclusion
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. GLOBAL MEDICAL AESTHETICS MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.3.1. Scenario Analysis
13.3.1.1. Conservative Scenario Analysis
13.3.1.2. Optimistic Scenario Analysis
13.4. Key Market Segmentations
13.5. Dynamic Dashboards
14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4. Data Triangulation and Validation
15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.4. Data Triangulation and Validation
16. MEDICAL AESTHETICS MARKET, BY END-USER
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Data Triangulation and Validation
17. MEDICAL AESTHETICS MARKET, BY GENDER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Data Triangulation and Validation
18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Data Triangulation and Validation
19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.4. Data Triangulation and Validation
20. MEDICAL AESTHETICS PRODUCTS MARKET
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Data Triangulation and Validation
21. EXECUTIVE INSIGHTS22. CONCLUSION23. APPENDIX 1: TABULATED DATA24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Market Landscape
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Funding and Investments
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Medical Aesthetics: Non-invasive Procedures
Figure 5.2 Medical Aesthetics: Invasive Procedures
Figure 5.3 Advantages of Medical Aesthetics
Figure 5.4 Side Effects of Medical Aesthetics
Figure 6.1 Medical Aesthetic Companies: Distribution by Year of Establishment
Figure 6.2 Medical Aesthetic Companies: Distribution by Company Size
Figure 6.3 Medical Aesthetic Companies: Distribution by Location of Headquarters (Region)
Figure 6.4 Medical Aesthetic Companies: Distribution by Location of Headquarters (Country)
Figure 6.5 Medical Aesthetic Companies: Distribution by Year of Establishment and Location of Headquarters (Region)
Figure 6.6 Medical Aesthetic Companies: Distribution by Company Size and Location of Headquarters (Region)
Figure 6.7 Medical Aesthetic Companies: Distribution by Type of Offering
Figure 6.8 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered
Figure 6.9 Medical Aesthetic Companies: Distribution by Type of Facial Aesthetic Products and / or Devices Offered
Figure 6.10 Medical Aesthetic Companies: Distribution by Type of Body Contouring Products and / or Devices Offered
Figure 6.11 Medical Aesthetic Companies: Distribution by Type of Hair Removal Devices Offered
Figure 6.12 Medical Aesthetic Companies: Distribution by Type of Breast Aesthetic Products and / or Devices Offered
Figure 6.13 Medical Aesthetic Companies: Distribution by Application Area
Figure 6.14 Medical Aesthetic Companies: Distribution by Type of Procedure
Figure 6.15 Medical Aesthetic Companies: Distribution by End-user
Figure 6.16 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered and Location of Headquarters (Region)
Figure 6.17 Medical Aesthetic Companies: Type of Procedure and Distribution by Location of Headquarters (Region)
Figure 7.1 Allergan Aesthetics: Annual Revenues, FY 2020-H1 FY 2023 (USD Billion)
Figure 7.2 Croma Pharma: Annual Revenues, FY 2021-H1 FY 2022 (EUR Million)
Figure 7.3 Galderma: Annual Revenues, FY 2020-FY H1 2023 (USD Billion)
Figure 7.4 Classys: Annual Revenues, FY 2020-H1 FY 2023 (KRW Million)
Figure 7.5 Establishment Labs: Annual Revenues, FY 2019-H1 FY 2023 (USD Million)
Figure 7.6 Shanghai Haohai Biological Technology: Annual Revenues, FY 2019-H1 FY 2023 (RMB Million)
Figure 8.1 Company Competitiveness Analysis: Companies based in North America (Peer Group I)
Figure 8.2 Company Competitiveness Analysis: Companies based in North America (Peer Group II)
Figure 8.3 Company Competitiveness Analysis: Companies based in Europe (Peer Group I)
Figure 8.4 Company Competitiveness Analysis: Companies based in Europe (Peer Group II)
Figure 8.5 Company Competitiveness Analysis: Companies based in Asia-Pacific and Rest of the World (Peer Group I)
Figure 8.6 Company Competitiveness Analysis: Companies based in Asia-Pacific and Rest of the World (Peer Group II)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2023
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2018-2023
Figure 9.4 Partnerships and Collaborations: Distribution by Focus Area
Figure 9.5 Most Active Players: Distribution by Number of Partnerships
Figure 9.6 Partnerships and Collaborations: Local and International Agreements
Figure 9.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Funding and Investments: Cumulative Year-wise Trend, 2018-2023
Figure 10.2 Funding and Investments: Distribution by Amount Invested (USD Million)
Figure 10.3 Funding and Investments: Distribution by Type of Funding
Figure 10.4 Funding and Investments: Distribution by Year and Type of Funding, 2018-2023
Figure 10.5 Funding and Investments: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 10.6 Funding and Investments: Distribution by Geography (Region)
Figure 10.7 Funding and Investments: Distribution by Geography (Country)
Figure 10.8 Most Active Players: Distribution by Number of Funding Instances
Figure 10.9 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 10.10 Leading Investors: Distribution by Number of Funding Instances
Figure 10.11 Funding and Investments: Distribution by Company Size and Amount Invested
Figure 10.12 Funding and Investments Summary, 2018-2023 (USD Million)
Figure 11.1 DELT Analysis: Impact of Internal and External Factors
Figure 11.2 DELT Analysis: Key Parameters
Figure 11.3 DELT Analysis: Allergan Aesthetics
Figure 11.4 DELT Analysis: Candela
Figure 11.5 DELT Analysis: Cutera
Figure 11.6 DELT Analysis: Biotechitalia
Figure 11.7 DELT Analysis: Sinclair Pharma
Figure 11.8 DELT Analysis: Merz Pharma
Figure 11.9 DELT Analysis: Dermosistemi
Figure 11.10 DELT Analysis: Alma Lasers
Figure 11.11 DELT Analysis: Bison Medical
Figure 11.12 DELT Analysis: Concluding Remarks
Figure 12.1 Market Drivers
Figure 12.2 Market Restraints
Figure 12.3 Market Opportunities
Figure 12.4 Market Challenges
Figure 13.1 Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 13.2 Global Medical Aesthetics Market, 2023-2035: Conservative Scenario (USD Million)
Figure 13.3 Global Medical Aesthetics Market, 2023-2035: Optimistic Scenario (USD Million)
Figure 13.4 Dynamic Dashboard
Figure 14.1 Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035 (USD Million)
Figure 14.2 Medical Aesthetics Market for Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.3 Medical Aesthetics Market for Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.4 Medical Aesthetics Market for Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.5 Medical Aesthetics Market for Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.6 Medical Aesthetics Market for Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.7 Medical Aesthetics Market for Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.8 Medical Aesthetics Market for Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.9 Medical Aesthetics Market for Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.1 Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035 (USD Million)
Figure 15.2 Medical Aesthetics Market for Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.3 Medical Aesthetics Market for Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.4 Medical Aesthetics Market for Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.1 Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035 (USD Million)
Figure 16.2 Medical Aesthetics Market for Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.3 Medical Aesthetics Market for Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.4 Medical Aesthetics Market for Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.1 Medical Aesthetics Market: by Distribution Channel, 2018, 2023 and 2035 (USD Million)
Figure 17.2 Medical Aesthetics Market for Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.3 Medical Aesthetics Market for Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 18.1 Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035 (USD Million)
Figure 18.2 Medical Aesthetics Market for Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 18.3 Medical Aesthetics Market for Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.1 Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Million)
Figure 19.2 Medical Aesthetics Market in North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.3 Medical Aesthetics Market in US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.4 Medical Aesthetics Market in Canada: Historical Trends (2019 2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.5 Medical Aesthetics Market in Mexico: Historical Trends (2019 2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.6 Medical Aesthetics Market in Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.7 Medical Aesthetics Market in UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.8 Medical Aesthetics Market in Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.9 Medical Aesthetics Market in France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.10 Medical Aesthetics Market in Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.11 Medical Aesthetics Market in Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.12 Medical Aesthetics Market in Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.13 Medical Aesthetics Market in Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.14 Medical Aesthetics Market in China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.15 Medical Aesthetics Market in South Korea: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.16 Medical Aesthetics Market in Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.17 Medical Aesthetics Market in India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.19 Medical Aesthetics Market in Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.19 Medical Aesthetics Market in Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.20 Medical Aesthetics Market in Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.21 Medical Aesthetics Market in Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.22 Medical Aesthetics Market in Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.23 Medical Aesthetics Market in Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.24 Medical Aesthetics Market in Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.25 Medical Aesthetics Market in Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.1 Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.2 Medical Aesthetics Products Market: Distribution by Type of Product Offered, 2018, 2023 and 2035 (USD Million)
Figure 20.3 Medical Aesthetics Products Market for Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.4 Medical Aesthetics Products Market for Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.5 Medical Aesthetics Products Market for Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.6 Medical Aesthetics Products Market for Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.7 Medical Aesthetics Products Market for Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.8 Medical Aesthetics Products Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Figure 20.9 Medical Aesthetics Products Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.10 Medical Aesthetics Products Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.11 Medical Aesthetics Products Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.12 Medical Aesthetics Products Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.13 Medical Aesthetics Products Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 21.1 Conclusion: Market Landscape
Figure 21.2 Conclusion: Partnerships and Collaborations
Figure 21.3 Conclusion: Funding and Investments
Figure 21.4 Conclusion: Market Forecast and Opportunity Analysis
LIST OF TABLES
Table 6.1 Medical Aesthetic Companies: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.2 Medical Aesthetic Companies: Information on Type of Offering
Table 6.3 Medical Aesthetic Companies: Information on Type of Products and / or Devices Offered
Table 6.4 Medical Aesthetic Companies: Information on Type of Facial Aesthetic Products and / or Devices Offered
Table 6.5 Medical Aesthetic Companies: Information on Type of Body Contouring Products and / or Devices, Hair Removal Devices and Breast Aesthetic Products and / or Devices Offered
Table 6.6 Medical Aesthetic Companies: Information on Application Area
Table 6.7 Medical Aesthetic Companies: Information on Type of Procedure and End-user
Table 7.1 Medical Aesthetics: List of Profiled Companies
Table 7.2 Allergan Aesthetics: Company Overview
Table 7.3 Allergan Aesthetics: Medical Aesthetics Portfolio
Table 7.4 Allergan Aesthetics: Recent Developments and Future Outlook
Table 7.5 Candela: Company Overview
Table 7.6 Candela: Medical Aesthetics Portfolio
Table 7.7 Cynosure: Company Overview
Table 7.8 Cynosure: Medical Aesthetics Portfolio
Table 7.9 Cynosure: Recent Developments and Future Outlook
Table 7.10 Lutronic: Company Overview
Table 7.11 Lutronic: Medical Aesthetics Portfolio
Table 7.12 Lutronic: Recent Developments and Future Outlook
Table 7.13 Mentor: Company Overview
Table 7.14 Mentor: Medical Aesthetics Portfolio
Table 7.15 BTL Aesthetics: Company Overview
Table 7.16 BTL Aesthetics: Medical Aesthetics Portfolio
Table 7.17 BTL Aesthetics: Recent Developments and Future Outlook
Table 7.18 Croma Pharma: Company Overview
Table 7.19 Croma Pharma: Medical Aesthetics Portfolio
Table 7.20 Croma Pharma: Recent Developments and Future Outlook
Table 7.21 Galderma: Company Overview
Table 7.22 Galderma: Medical Aesthetics Portfolio
Table 7.23 Galderma: Recent Developments and Future Outlook
Table 7.24 IBSA: Company Overview
Table 7.25 IBSA: Medical Aesthetics Portfolio
Table 7.26 IBSA: Recent Developments and Future Outlook
Table 7.27 Sinclair: Company Overview
Table 7.28 Sinclair: Medical Aesthetics Portfolio
Table 7.29 Sinclair: Recent Developments and Future Outlook
Table 7.30 Classys: Company Overview
Table 7.31 Classys: Medical Aesthetics Portfolio
Table 7.32 Classys: Recent Developments and Future Outlook
Table 7.33 Daeyang Medical: Company Overview
Table 7.34 Daeyang Medical: Medical Aesthetics Portfolio
Table 7.35 Establishment Labs: Company Overview
Table 7.36 Establishment Labs: Medical Aesthetics Portfolio
Table 7.37 Establishment Labs: Recent Developments and Future Outlook
Table 7.38 Lumenis: Company Overview
Table 7.39 Lumenis: Medical Aesthetics Portfolio
Table 7.40 Shanghai Haohai Biological Technology: Company Overview
Table 7.41 Shanghai Haohai Biological Technology: Medical Aesthetics Portfolio
Table 7.42 ADSS: Company Overview
Table 7.43 ADSS: Medical Aesthetics Portfolio
Table 7.44 Astiland: Company Overview
Table 7.45 Astiland: Medical Aesthetics Portfolio
Table 7.46 Beijing Kes Biological Technology: Company Overview
Table 7.47 Beijing Kes Biological Technology: Medical Aesthetics Portfolio
Table 7.48 Guangzhou Itech Aesthetics: Company Overview
Table 7.49 Guangzhou Itech Aesthetics: Medical Aesthetics Portfolio
Table 7.50 MedicalZone: Company Overview
Table 7.51 MedicalZone: Medical Aesthetics Portfolio
Table 7.52 Sanhe Medical: Company Overview
Table 7.53 Sanhe Medical: Medical Aesthetics Portfolio
Table 7.54 Sincoheren: Company Overview
Table 7.55 Sincoheren: Medical Aesthetics Portfolio
Table 7.56 Skin Tech Pharma: Company Overview
Table 7.57 Skin Tech Pharma: Medical Aesthetics Portfolio
Table 7.58 Wontech: Company Overview
Table 7.59 Wontech: Medical Aesthetics Portfolio
Table 7.60 Zesay Beauty: Company Overview
Table 7.61 Zesay Beauty: Medical Aesthetics Portfolio
Table 9.1 Medical Aesthetics: List of Partnerships and Collaborations
Table 9.2 Partnerships and Collaborations: Information on Location of Headquarters (Country and Region) and Type of Agreement (Country and Region)
Table 10.1 Medical Aesthetics: List of Funding and Investments
Table 11.1 Medical Aesthetics: Impact of Internal and External Factors on Key Players
Table 21.1 Medical Aesthetic Companies: Distribution by Year of Establishment
Table 21.2 Medical Aesthetic Companies: Distribution by Company Size
Table 21.3 Medical Aesthetic Companies: Distribution by Location of Headquarters (Region)
Table 21.4 Medical Aesthetic Companies: Distribution by Location of Headquarters (Country)
Table 21.5 Medical Aesthetic Companies: Distribution by Year of Establishment and Location of Headquarters (Region)
Table 21.6 Medical Aesthetic Companies: Distribution by Company Size and Location of Headquarters (Region)
Table 21.7 Medical Aesthetic Companies: Distribution by Type of Offering
Table 21.8 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered
Table 21.9 Medical Aesthetic Companies: Distribution by Type of Facial Aesthetic Products and / or Devices Offered
Table 21.10 Medical Aesthetic Companies: Distribution by Type of Body Contouring Products and / or Devices Offered
Table 21.11 Medical Aesthetic Companies: Distribution by Type of Hair Removal Devices Offered
Table 21.12 Medical Aesthetic Companies: Distribution by Type of Breast Aesthetic Products and / or Devices Offered
Table 21.13 Medical Aesthetic Companies: Distribution by Application Area
Table 21.14 Medical Aesthetic Companies: Distribution by Type of Procedure
Table 21.15 Medical Aesthetic Companies: Distribution by End-user
Table 21.16 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered and Location of Headquarters (Region)
Table 21.17 Medical Aesthetic Companies: Distribution by Type of Procedure and Location of Headquarters (Region)
Table 21.18 Allergan Aesthetics: Annual Revenues, FY 2020-H1 FY 2023 (USD Billion)
Table 21.19 Croma Pharma: Annual Revenues, FY 2021-FY 2022 (EUR Million)
Table 21.20 Galderma: Annual Revenues, FY 2020- H1 FY 2023 (USD Billion)
Table 21.21 Classys: Annual Revenues, FY 2020- H1 FY 2023 (KRW Million)
Table 21.22 Establishment Labs: Annual Revenues, FY 2019-FY H1 2023 (USD Million)
Table 21.23 Shanghai Haohai Biological Technology: Annual Revenues, FY 2019- H1 FY 2023 (RMB Million)
Table 21.24 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2023
Table 21.25 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.26 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2018-2023
Table 21.27 Partnerships and Collaborations: Distribution by Focus Area
Table 21.28 Most Active Players: Distribution by Number of Partnerships
Table 21.29 Partnerships and Collaborations: Local and International Agreements
Table 21.30 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 21.31 Funding and Investments: Cumulative Year-wise Trend, 2018-2023
Table 21.32 Funding and Investments: Distribution by Type of Funding
Table 21.33 Funding and Investments: Distribution by Amount Invested (USD Million)
Table 21.34 Funding and Investments: Distribution by Year and Type of Funding, 2018-2023
Table 21.35 Funding and Investments: Distribution by Type of Funding and Amount Invested (USD Million)
Table 21.36 Funding and Investments: Distribution by Geography (Region)
Table 21.37 Funding and Investments: Distribution by Geography (Country)
Table 21.38 Most Active Players: Distribution by Number of Funding Instances
Table 21.39 Most Active Players: Distribution by Amount Raised (USD Million)
Table 21.40 Leading Investors: Distribution by Number of Funding Instances
Table 21.41 Funding and Investments: Distribution by Company Size and Amount Invested
Table 21.42 Funding and Investments Summary, 2018-2023 (USD Million)
Table 21.43 Global Medical Aesthetics Market, 2018-2022 (USD Million)
Table 21.44 Global Medical Aesthetics Market, 2023-2035 (USD Million)
Table 21.45 Global Medical Aesthetics Market, 2023-2035: Conservative Scenario (USD Million)
Table 21.46 Global Medical Aesthetics Market, 2023-2035: Optimistic Scenario (USD Million)
Table 21.47 Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035 (USD Million)
Table 21.48 Medical Aesthetics Market for Botox, 2018-2022 (USD Million)
Table 21.49 Medical Aesthetics Market for Botox, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.50 Medical Aesthetics Market for Dermal Fillers, 2018-2022 (USD Million)
Table 21.51 Medical Aesthetics Market for Dermal Fillers, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.52 Medical Aesthetics Market for Chemical Peels, 2018-2022 (USD Million)
Table 21.53 Medical Aesthetics Market for Chemical Peels, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.54 Medical Aesthetics Market for Body Contouring, 2018-2022 (USD Million)
Table 21.55 Medical Aesthetics Market for Body Contouring, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.56 Medical Aesthetics Market for Hair Removal, 2018-2022 (USD Million)
Table 21.57 Medical Aesthetics Market for Hair Removal, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.58 Medical Aesthetics Market for Breast Implants, 2018-2022 (USD Million)
Table 21.59 Medical Aesthetics Market for Breast Implants, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.60 Medical Aesthetics Market for Gluteal Implants, 2018-2022 (USD Million)
Table 21.61 Medical Aesthetics Market for Gluteal Implants, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.62 Medical Aesthetics Market for Other Products and / or Devices, 2018-2022 (USD Million)
Table 21.63 Medical Aesthetics Market for Other Products and / or Devices, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.64 Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035 (USD Million)
Table 21.65 Medical Aesthetics Market for Non-invasive Procedures, Conservative, 2018-2022 (USD Million)
Table 21.66 Medical Aesthetics Market for Non-invasive Procedures, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.67 Medical Aesthetics Market for Minimally Invasive Procedures, 2018-2022 (USD Million)
Table 21.68 Medical Aesthetics Market for Minimally Invasive Procedures, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.69 Medical Aesthetics Market for Invasive Procedures, 2018-2022 (USD Million)
Table 21.70 Medical Aesthetics Market for Invasive Procedures, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.71 Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035 (USD Million)
Table 21.72 Medical Aesthetics Market for Hospitals, 2018-2022 (USD Million)
Table 21.73 Medical Aesthetics Market for Hospitals, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.74 Medical Aesthetics Market for Clinics / Med Spas and Dermatology / Cosmetology Centers, 2018-2022 (USD Million)
Table 21.75 Medical Aesthetics Market for Clinics / Med Spas and Dermatology / Cosmetology Centers, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.76 Medical Aesthetics Market for Other End-users, 2018-2022 (USD Million)
Table 21.77 Medical Aesthetics Market for Other End-users, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.78 Medical Aesthetics Market: by Distribution Channel, 2018, 2023 and 2035 (USD Million)
Table 21.79 Medical Aesthetics Market for Direct Distribution, 2018-2022 (USD Million)
Table 21.80 Medical Aesthetics Market for Direct Distribution, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.81 Medical Aesthetics Market for Indirect Distribution, 2018-2022 (USD Million)
Table 21.82 Medical Aesthetics Market for Indirect Distribution, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.83 Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035 (USD Million)
Table 21.84 Medical Aesthetics Market for Males, Conservative, 2018-2022 (USD Million)
Table 21.85 Medical Aesthetics Market for Males, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.86 Medical Aesthetics Market for Females, 2018-2022 (USD Million)
Table 21.87 Medical Aesthetics Market for Females, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.88 Medical Aesthetics Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Table 21.89 Medical Aesthetics Market in North America, 2018-2022 (USD Million)
Table 21.90 Medical Aesthetics Market in North America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.91 Medical Aesthetics Market in US, 2018-2022 (USD Million)
Table 21.92 Medical Aesthetics Market in US, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.93 Medical Aesthetics Market in Canada, 2018-2022 (USD Million)
Table 21.94 Medical Aesthetics Market in Canada, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.95 Medical Aesthetics Market in Mexico, 2018-2022 (USD Million)
Table 21.96 Medical Aesthetics Market in Mexico, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.97 Medical Aesthetics Market in Europe, 2018-2022 (USD Million)
Table 21.98 Medical Aesthetics Market in Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.99 Medical Aesthetics Market in UK, 2018-2022 (USD Million)
Table 21.100 Medical Aesthetics Market in UK, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.101 Medical Aesthetics Market in Germany, 2018-2022 (USD Million)
Table 21.102 Medical Aesthetics Market in Germany, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.103 Medical Aesthetics Market in France, 2018-2022 (USD Million)
Table 21.104 Medical Aesthetics Market in France, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.105 Medical Aesthetics Market in Italy, 2018-2022 (USD Million)
Table 21.106 Medical Aesthetics Market in Italy, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.107 Medical Aesthetics Market in Spain, 2018-2022 (USD Million)
Table 21.108 Medical Aesthetics Market in Spain, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.109 Medical Aesthetics Market in Rest of the Europe, 2018-2022 (USD Million)
Table 21.110 Medical Aesthetics Market in Rest of the Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.111 Medical Aesthetics Market in Asia-Pacific, 2018-2022 (USD Million)
Table 21.112 Medical Aesthetics Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.113 Medical Aesthetics Market in China, 2018-2022 (USD Million)
Table 21.114 Medical Aesthetics Market in China, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.115 Medical Aesthetics Market in South Korea, 2018-2022 (USD Million)
Table 21.116 Medical Aesthetics Market in South Korea, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.117 Medical Aesthetics Market in Japan, 2018-2022 (USD Million)
Table 21.118 Medical Aesthetics Market in Japan, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.119 Medical Aesthetics Market in India, 2018-2022 (USD Million)
Table 21.120 Medical Aesthetics Market in India, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.121 Medical Aesthetics Market in Middle East and North Africa, 2018-2022 (USD Million)
Table 21.122 Medical Aesthetics Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.123 Medical Aesthetics Market in Turkey, 2018-2022 (USD Million)
Table 21.124 Medical Aesthetics Market in Turkey, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.125 Medical Aesthetics Market in Iran, 2018-2022 (USD Million)
Table 21.126 Medical Aesthetics Market in Iran, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.127 Medical Aesthetics Market in Rest of the Middle East and North Africa, 2018-2022 (USD Million)
Table 21.128 Medical Aesthetics Market in Rest of the Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.129 Medical Aesthetics Market in Latin America, 2018-2022 (USD Million)
Table 21.130 Medical Aesthetics Market in Latin America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.131 Medical Aesthetics Market in Brazil, 2018-2022 (USD Million)
Table 21.132 Medical Aesthetics Market in Brazil, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.133 Medical Aesthetics Market in Argentina, 2018-2022 (USD Million)
Table 21.134 Medical Aesthetics Market in Argentina, 2023-2035 (USD Million)
Table 21.135 Medical Aesthetics Market in Rest of the Latin America, 2018-2022 (USD Million)
Table 21.136 Medical Aesthetics Market in Rest of the Latin America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.137 Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.138 Medical Aesthetics Products Market: Distribution by Type of Product Offered 2023-2035 (USD Million)
Table 21.139 Medical Aesthetics Products Market for Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.140 Medical Aesthetics Products Market for Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.141 Medical Aesthetics Products Market for Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.142 Medical Aesthetics Products Market for Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.143 Medical Aesthetics Products Market for Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.144 Medical Aesthetics Products Market : Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Table 21.145 Medical Aesthetics Products Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.146 Medical Aesthetics Products Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.147 Medical Aesthetics Products Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.148 Medical Aesthetics Products Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.149 Medical Aesthetics Products Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3D Aesthetics
  • 3D Systems
  • AbbVie
  • Abell Foundation
  • Abu Dhabi Investment Authority
  • ACROSS
  • ADODERM
  • ADSS
  • Advalight
  • Aeon Pharma
  • Aerolase
  • Aestura (a subsidiary of Amorepacific)
  • AGNES MEDICAL
  • ALASTIN Skincare
  • Allergan Aesthetics 
  • Alma Lasers
  • Alpha aesthetics
  • Alpha Investment
  • Alsanza Medizintechnik und Pharma 
  • Alteon
  • AMI
  • AMP
  • AngelMD
  • Anzu Partners
  • APX Platform
  • Apyx Medical
  • Aquavit
  • ARCH Venture Partners
  • Asclepion 
  • ASPIOON 
  • Astiland
  • Athyrium Capital Management
  • Australian Skin Clinics
  • Avenue Venture Opportunities Fund
  • Barak Capital Underwriters
  • Beauty Aesthetic
  • BeautyCom Biotechnology
  • Beijing KES Biology Technology
  • Beijing Sanhe Technology
  • BENEV
  • BES
  • Beyond Medical Aesthetics
  • Bimini Health Tec
  • Biomatics Capital
  • BioPlus
  • Bioscience
  • Biotech Italia
  • Bioxis pharmaceuticals
  • Bison Medical
  • BNC Korea
  • BPI
  • BR Meditech
  • Brera Medical Technologies
  • BTL Aesthetics
  • BVLaser
  • Caliway Biopharmaceuticals
  • Candela
  • Canons Clinics
  • Cartessa Aestherics
  • CD&R
  • CELLINK
  • ChiMin Health Management
  • ChungWoo
  • Clairderm Medical Aesthetics
  • Clarion Medical Technologies
  • CLASSYS
  • ClinicalPRO
  • Clinipro
  • Clinisept+
  • CMed Aesthetics
  • Cocoon Medical
  • Cogmedix (a subsidiary of Coghlin Companies)
  • CollPlant Biotechnologies
  • Croma-Pharma
  • Crown Aesthetics
  • Crown Laboratories
  • Cutera
  • Cynosure
  • Cypris Medical
  • Cytophil
  • Cytrellis Biosystems
  • D1 Capital Partners
  • Daeyang Medical
  • Decomedical
  • Deerfield Management 
  • Deka Aesthetics 
  • Deleo
  • DermapenWorld
  • Dermosistemi
  • Dimed Laser
  • Dominion Aesthetic Technologies
  • Dongwha Pharm
  • DTA Medical
  • DubiMed
  • E.S.I Novel
  • Ecleris
  • Eclipse Med
  • EIC Accelerator
  • Eirion Therapeutics
  • ELESTA
  • EMA Aesthetics
  • EME
  • Emerald Development Managers
  • EMK Medical
  • EmShape Korea
  • ENDYMED
  • EQT Partners
  • Erchonia
  • Establishment Labs
  • Etoile
  • Evolus
  • EW Healthcare Partners
  • ExoCoBio
  • F Care Systems
  • FILLMED
  • FineMEC
  • Finovam Gestion
  • Fisoline
  • FONGIT Innovation Fund
  • Formatk
  • Fotona
  • Funshine
  • Galderma
  • Gale Force Aesthetics
  • GC Aesthetics
  • Genesis Biosystems
  • German Medical Engineering
  • GIGAALASER
  • GPQ Srl
  • Guangzhou iTech Aesthetics
  • Guangzhou zesaybeauty
  • HAEMATO
  • Hahn & Company
  • Hakomed Italia
  • Harley Technologies
  • Harrods
  • Hayfin Capital Management
  • HealthQuest Capital
  • Hildred Capital Partners
  • Hironic
  • HTDK
  • HTL
  • Huadong Medicine
  • Hugel Aesthetics
  • Huons BioPharma
  • Huons Meditech
  • HYALURONICA
  • IBSA
  • IDEAL IMPLANT
  • INDIBA
  • InMode
  • Innooaesthetics
  • invisa-RED
  • Iskra Medical
  • Jeisys Medical
  • Jetema
  • JUVA
  • Kairos Venture Investments
  • Koru Pharma
  • KYLANE LABORATOIRES
  • KYLYS
  • Laser Lipo
  • Laserconn
  • LASEROPTEK
  • LasMedTech
  • Lattice Medical
  • LAYUN KOREA
  • Leaflife
  • LED SpA
  • Ledsmedical
  • Legolaser
  • LifeSprout
  • LINLINE Medical Systems
  • Love Cosmedical
  • LP Aesthetics
  • Lumenis
  • Luminera
  • LumiSKN
  • Luna Clinic
  • Lutronic
  • LUVO Medical
  • Lynton Surgical
  • M&T Srl
  • MagnaSci Ventures
  • Mantis Srl
  • Mastelli
  • Masters Special Situations
  • Maya Beauty Engineering (MBE)
  • McNAIR
  • MECA
  • MedArt Technology
  • MedicalZone
  • Mediserve
  • MedTech Lasers
  • Medytox
  • Mentor 
  • Merz Pharma
  • mesoestetic
  • Mesotech Srl
  • Meyer-Haake
  • MicroAire
  • MidCap Financial
  • milesman
  • Monarch Laser Services
  • Montreux Growth Partners
  • Morton Cohn Investments
  • My Med Aesthetics
  • MyEllevate
  • Natieco
  • National Futures Association
  • National Ultrasound
  • Neauvia
  • NEDAL
  • NEOconcepts
  • NeoGenesis
  • NewBeauty
  • Newpong
  • Nexus Management
  • NGH Aesthetics
  • NIUU Medical Aesthetics
  • Nord France Amorçage
  • Nova Medical
  • Nova Threads
  • NovaVision
  • Novoxel
  • Noxogen Therapeutics
  • NYUMA PHARMA
  • Oaktree Capital Management
  • Oxford Finance
  • Oyster Capital Partners
  • PB&B
  • PFM Health Sciences
  • Phanes Beauty
  • Pharmaesthetics
  • Pharmakon Advisors
  • PharmaResearch
  • PhaseTech
  • PhotoMedex
  • Pollogen
  • POLYTECH Health & Aesthetics
  • Powered by MRP
  • Priveterra
  • Pro 1 Laser
  • ProCell Therapeutics
  • Professional Dietetics
  • Prollenium Medical Technologies
  • Promoitalia
  • Quanta System
  • Qventis
  • Redmile
  • REGENBOGEN
  • Restoration Robotics
  • Revance Therapeutics
  • Reveal Lasers
  • Revelle Aesthetics
  • Robosculptor
  • Rohrer Aesthetics
  • Sands Capital
  • Santelys
  • Sapphire Aesthetics
  • Sciton
  • SciVision Biotech
  • Seishin Plastic and Aesthetic Surgery Clinic
  • Shanghai Apolo Medical Technology
  • Shanghai Fosun Pharmaceutical
  • Shanghai Haohai Biological Technology
  • SharpLight Technologies
  • Shenzen GSD Tech
  • Sientra
  • SILK Laser Clinics
  • Silk Medical Aesthetics
  • Sinclair Pharma
  • Sincoheren
  • Skin Tech Pharma
  • Smedtrum
  • SNJ
  • Sofregen
  • Softwave Medical
  • Soliton
  • Solta Medical 
  • Stratasys
  • Suisselle
  • Suneva Medical
  • Symatese
  • Synergy 
  • TavTech
  • TEDCO
  • Tema Medicina
  • Teoxane
  • The Perfect Peel
  • TriCell Aesthetics
  • Trinity Capital
  • Triskelion Investments
  • TRIWORKS
  • UMECO
  • Union Medical
  • Venus Concept

Methodology

 

 

Loading
LOADING...

Table Information